Professor Martin Landray, from the College of Oxford professor, is co-leading the UK trial of the monoclonal antibody therapy, which is getting used on President Trump.

Professor Landray mentioned the Regeneron drug helps stops the virus stepping into cells, and has proven “promising outcomes” in trials.



Source link

Share and Enjoy !

0Shares
0 0

LEAVE A REPLY

Please enter your comment!
Please enter your name here